186 related articles for article (PubMed ID: 4368955)
1. Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia.
McDonald AD; Williams MC; Manfreda J; West R
Am J Epidemiol; 1974 Aug; 100(2):130-5. PubMed ID: 4368955
[No Abstract] [Full Text] [Related]
2. Prospective studies of the association of genital herpes simplex infection and cervical anaplasia.
Nahmias AJ; Naib ZM; Josey WE; Franklin E; Jenkins R
Cancer Res; 1973 Jun; 33(6):1491-7. PubMed ID: 4352387
[No Abstract] [Full Text] [Related]
3. An analysis of seroepidemiological studies of herpesvirus type 2 and carcinoma of the cervix.
Rawls WE; Adam E; Melnick JL
Cancer Res; 1973 Jun; 33(6):1477-82. PubMed ID: 4352385
[No Abstract] [Full Text] [Related]
4. Expression of herpesvirus-induced antigens in human cervical cancer.
Dreesman GR; Burek J; Adam E; Kaufman RH; Melnick JL; Powell KL; Purifoy DJ
Nature; 1980 Feb; 283(5747):591-3. PubMed ID: 6243743
[No Abstract] [Full Text] [Related]
5. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. IV. Dysplasia and carcinoma in situ.
Adam E; Kaufman RH; Melnick JL; Levy AH; Rawls WE
Am J Epidemiol; 1973 Aug; 98(2):77-87. PubMed ID: 4724998
[No Abstract] [Full Text] [Related]
6. A study of herpes simplex type 2 antibody status in groups of patients with cervical neoplasia in Czechoslovakia.
Janda Z; Kanka J; Vonka V; Svoboda B
Int J Cancer; 1973 Nov; 12(3):626-30. PubMed ID: 4364794
[No Abstract] [Full Text] [Related]
7. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. II. Uganda.
Adam E; Sharma SD; Zeigler O; Iwamoto K; Melnick JL; Levy AH; Rawls WE
J Natl Cancer Inst; 1972 Jan; 48(1):65-72. PubMed ID: 4347030
[No Abstract] [Full Text] [Related]
8. Antibody to Herpesvirus hominis in patients with carcinoma of the cervix.
Najem SN; Barton IG; Al-Omar LS; Potter CW
Br J Exp Pathol; 1982 Oct; 63(5):485-9. PubMed ID: 6293526
[TBL] [Abstract][Full Text] [Related]
9. Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls.
Feorino PM; Palmer EL
J Infect Dis; 1973 Jun; 127(6):732-5. PubMed ID: 4350521
[No Abstract] [Full Text] [Related]
10. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
[TBL] [Abstract][Full Text] [Related]
11. Increasing antibody titers to herpes simplex virus type 2 during follow-up of women with cervical dysplasia.
Sprecher-Goldberger S; Thiry L; Gould I; Fassin Y; Gompel C
Am J Epidemiol; 1973 Feb; 97(2):103-10. PubMed ID: 4347508
[No Abstract] [Full Text] [Related]
12. Neutralizing antibodies to herpesvirus types 1 and 2 in Montreal women.
McDonald AD; Williams MC; West R; Stewart J
Am J Epidemiol; 1974 Aug; 100(2):124-9. PubMed ID: 4368956
[No Abstract] [Full Text] [Related]
13. Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls.
Pacsa AS; Kummerländer L; Pejtsik B; Pali K
J Natl Cancer Inst; 1975 Oct; 55(4):775-81. PubMed ID: 171424
[TBL] [Abstract][Full Text] [Related]
14. Relationship of herpes simplex virus type-2 antibodies and squamous dysplasia to cervical carcinoma in situ.
Thomas DB; Rawls WE
Cancer; 1978 Dec; 42(6):2716-25. PubMed ID: 215294
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological studies relating genital herpetic infection to cervical carcinoma.
Nahmias AJ; Naib ZM; Josey WE
Cancer Res; 1974 May; 34(5):1111-7. PubMed ID: 4366985
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to herpesvirus hominis types 1 and 2 among women with neoplastic change of uterine cervix.
Peltonen R
Acta Obstet Gynecol Scand; 1975; 54(4):369-72. PubMed ID: 173131
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus antibody in south Indian patients with carcinoma cervix.
Seshadri L; Seth P; Walter A; Seshadri MS; John TJ
Indian J Med Res; 1984 Jan; 79():13-8. PubMed ID: 6327511
[No Abstract] [Full Text] [Related]
18. Antibodies to herpesvirus type 1 and type 2 among Japanese cervical cancer patients.
Ozaki Y; Ishiguro T; Ohashi M; Sawaragi I; Ito Y
Gan; 1978 Feb; 69(1):119-22. PubMed ID: 640320
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes.
Najem SN; Vestergaard BF; Potter CW
Acta Pathol Microbiol Immunol Scand B; 1983 Jun; 91(3):205-7. PubMed ID: 6308950
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiologic characteristics and virologic findings in women with precanceroses and carcinoma of the uterine cervix].
Kanka J; Vonka V; Havránková A; Svoboda B; Váchal M; Subrt I; Hirsch I; Závadová H; Krcmár M; Broucek J
Cesk Gynekol; 1985 Nov; 50(9):651-6. PubMed ID: 3002641
[No Abstract] [Full Text] [Related]
[Next] [New Search]
